Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510519 · ClinicalTrials.gov registry record
Scaling Mental Healthcare in COVID-19 With Voice Biomarkers
A clinical trial, sponsored by Kintsugi Mindful Wellness.
- Completed
- Registry status
- 20
- Enrollment target
NCT04510519: Completed study, sponsored by Kintsugi Mindful Wellness.
NCT04510519 is a clinical trial that has completed, run by Kintsugi Mindful Wellness. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04510519 has completed, sponsored by Kintsugi Mindful Wellness.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study aims to advance research on group sessions for mental health. The first-of-its-kind study measuring various features in a group setting, combining rich metadata in creating state-of-the-art machine learning models, and developing workflows for mental health that are both scalable and personalized.
Primary Outcome
A repeated measures, within-subject design using exploratory techniques will identify the best group session features or combination of features that correlate with or predict change on the PHQ-9.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-12 |
| Est. Completion | 2022-03-02 |
What the finished NCT04510519 record still lists
NCT04510519 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04510519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04510519 about?
NCT04510519 is a clinical study titled "Scaling Mental Healthcare in COVID-19 With Voice Biomarkers". This study aims to advance research on group sessions for mental health. The first-of-its-kind study measuring various features in a group setting, combining rich metadata in creating state-of-the-art machine learning models, and developing workflows for mental health that are both scalable and pers...
What is the current status of trial NCT04510519?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-01-12. Estimated completion is 2022-03-02.
Who is sponsoring clinical trial NCT04510519?
This trial is sponsored by Kintsugi Mindful Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI